Reactive oxygen species (ROS) are causative factors of degenerative diseases, including some hepatopathies ([@CIT0001]). The overproduction of ROS and therefore oxidative stress can be initiated by a variety of factors, including exposure to xenobiotics, such as acetaminophen and carbon tetrachloride (CCl~4~) ([@CIT0002]). CCl~4~ has been extensively used to study liver injury induced by ROS in the mouse model, which is closely analogous to hepatotoxicity in humans. The hepatotoxic effect of CCl~4~ is thought to be initiated as a result of its reductive dehalogenation by cytochrome P450 2E1 to the highly reactive trichloromethyl radical (^•^CCl~3~), which is subsequently converted into a trichloromethyl peroxyl radical (^•^OOCCl~3~) in the presence of oxygen ([@CIT0003]). Removal of hydrogen atoms from unsaturated fatty acids by such radicals generates carbon-centered lipid radicals. These lipid radicals quickly add molecular oxygen to form lipid peroxyl radicals, thereby initiating the process of lipid peroxidation (LPO). Unless neutralized by radical scavengers, these peroxyl radicals in turn abstract hydrogen atoms from other lipid molecules, thereby propagating the process of LPO ([@CIT0004]). Also, ^•^CCl~3~ can react with sulfhydryl groups, such as reduced glutathione (GSH) and protein thiols, which eventually leads to abnormal protein function, membrane LPO and, consequently, damage to mitochondria and nuclei, leading to impaired physiological functions of hepatocytes, and finally, to cell necrosis ([@CIT0005]).

In this sense, the antioxidant action plays an important role in protecting against CCl~4~-induced liver injury. Protective effects of various natural and synthetic products against hepatotoxicity have been reported ([@CIT0006]--[@CIT0008]). Phenolic compounds or polyphenols, which consist of secondary vegetal metabolites, constitute a wide and complex array of phytochemicals that exhibit antioxidant action ([@CIT0009]). Among the phenolic compounds, some acetophenones possess several biological properties ([@CIT0010]). It has been reported by Mathiesen and collaborators ([@CIT0011]) that phloroacetophenone (2′,4′,6′-trihydroxyacetophenone -- THA; [Fig. 1](#F0001){ref-type="fig"}) exercises its antioxidant activity *in vitro* by scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH), but no further investigations were carried out. THA is the aglycone part of a glycoside from *Myrcia multiflora* (family Myrtaceae), a plant popularly known as 'insulin plant' and used for diabetes in traditional medicine in South America. The literature cites several sources for obtaining phloroacetophenone derivatives, but the free form of acylphloroglucinol is rare ([@CIT0012]--[@CIT0014]). Isolated flavanone and flavonol glucosides have been reported to inhibit aldose reductase and α-glucosidase activities and to possess a potential for hypoglycemic activity in alloxan-induced diabetic animals ([@CIT0015], [@CIT0016]). But only studies that describe the antioxidant effect and hepatoprotector of THA are available.

![Chemical structure of 2′,4′,6′-trihydroxyacetophenone (phloroacetophenone, THA).](LJM-5-4891-g001){#F0001}

Here, we investigated both the *in vitro* and *in vivo* antioxidant activity and the potential protective effects of THA in CCl~4~-induced hepatotoxicity in mice. The protective activity of THA was compared with that of Silymarin (SIL), a natural antioxidant that has been used in clinical practice for the treatment of toxic liver disease ([@CIT0017]). This study was carried out taking into consideration that THA possesses a beneficial activity as an antioxidant and hepatoprotective agent, although the mechanism for the activity remains to be elucidated.

Materials and methods {#S0001}
=====================

Chemicals {#S20002}
---------

All chemicals were of the highest commercially available purity. THA monohydrate was from Fluka. All other chemicals were from Sigma-Aldrich Co.

Plant material and isolation of phloracetophenone glucoside {#S20003}
-----------------------------------------------------------

The leaves of cultivated *M. multiflora* were obtained from Albano Ferreira Martins, Ltd., São Paulo, Brazil. The dried leaves of *M. multiflora* were subjected to the methods of extraction and isolation of phloracetophenone glucoside according to Suksamraran and collaborators ([@CIT0018]). The compound was isolated and identified by preparative TLC and analyzed by ^1^H NMR. IR showed that data were consistent with those reported for the 4,6-dihydroxy-2-O-(β-D-glucopyranosyl) acetophenone. Indeed, by the acidic hydrolysis of the compound mentioned above, it is possible to prepare the THA.

To obtain phloroacetophenone, 4,6-dihydroxy-2-O-(β-D-glucopyranosyl) acetophenone (200 mg) was treated with 3 N HCl in methanol (200 ml) at a reflux temperature of 100°C for 30 min ([@CIT0018]--[@CIT0020]). After neutralization by careful addition of 20% aqueous NaHCO~3~ and elimination of methanol under vacuum and controlled temperature, the phloracetophenone was extracted with CH~2~Cl~2~, followed by the evaporation of solvent and recrystallization with boiling water. This yielded crystals of colorless needles that were submitted to ^1^H NMR, IR, and TLC analyses with a synthetic standard of THA monohydrate. Analytical TLC was carried out on 0.2-mm plates of silica gel 60 F~254~ (Merck, Darmstadt). For separation and identification of compounds, the following mobile phases (a, b) and spray reagent (c) were used: (a) AcOet--H~2~CO~2~--HOAc--H~2~O (500:5:5:2); (b) CHCl~3~--(CH~3~)~2~CO--H~2~CO~2~ (150:33:17), and (c) vanillin/H~2~SO~4~ (10% vanillin in a 2:1 mixture of 99.5% ethanol and concentrated H~2~SO~4~), followed by heating for color development.

In vitro antioxidant activity {#S20004}
-----------------------------

The free radical scavenging activity of THA was evaluated using the 2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) radical scavenger method and measured at 518 nm ([@CIT0021]). Superoxide anion ($\text{O}_{2}^{\bullet-}$) was measured according to Robak and Gryglewski ([@CIT0022]), using its generation through xanthine/xanthine oxidase and detected by nitro blue tetrazolium (NBT) reduction at 560 nm. The hydroxyl radical (^•^OH) was generated by the deoxyribose method and its reaction with thiobarbituric acid (TBA) was indirectly detected through the pink chromophore measured at 532 nm ([@CIT0023]). LPO was assayed using the TBA method, as described by Chen and Tappel ([@CIT0024]). THA antioxidant activities *in vitro* were evaluated in triplicates in the range 0.5 to 500 µg/ml and the results were expressed as IC~50~, which was the concentration (in µg/ml) of THA required to inhibit the generation rates of radicals by 50%. SIL, a mixture of four flavonolignans that possesses a recognized ROS scavenger activity as well as a hepatoprotective effect, was used as the antioxidant standard ([@CIT0017]).

Animals {#S20005}
-------

Male Swiss mice, supplied by the local Bioterio Central of the Federal University of Santa Catarina and weighing 25±5 g, were housed under controlled conditions (12-h light--dark cycle, 22±2°C, 60% air humidity), and had free access to standard laboratory chow and water. All animal procedures were conducted in accordance with legal requirements appropriate to the species (Guiding Principles for the Care and Use of Laboratory Animals, NIH publication \#85.23, revised in 1985) and with the approval of the local Ethics Committee.

Hepatoprotective activity {#S20006}
-------------------------

Hepatotoxicity was induced by CCl~4~ (0.5 ml/kg body weight in olive oil, injected intraperitoneally) according to the method described by Carbonari et al. ([@CIT0007]). THA was preliminarily evaluated at 3, 6, and 12 mg/kg body weight and the dose of 6 mg/kg was selected because it was the lowest dose that could normalize the hepatic enzymes aspartate amino transferase (AST), alanine amino transferase (ALT), and lactate dehydrogenase (LDH). Mice were randomly divided into five groups (*n*=6 each group) and administered orally by gavage during 7 days as follows:Group I: Control group, treated with vehicle (saline) daily for 7 days.Group II: Treated with vehicle (saline) daily for 7 days followed by CCl~4~ on day 7.Group III: Treated with THA (6 mg/kg) daily for 7 days.Group IV: Treated with THA (6 mg/kg) daily for 7 days followed by CCl~4~ on day 7.Group V: Treated with SIL (24 mg/kg) daily for 7 days.Group VI: Treated with SIL (24 mg/kg) daily for 7 days followed by CCl~4~ on day 7.Approximately 24 h after the i.p. administration of CCl~4~, blood sample was collected and serum was separated to evaluate the biochemical markers of hepatic injury. After that, animals were euthanized by cervical dislocation and the livers were immediately excised, weighed, and kept on ice for analysis of biomarkers of oxidative damage, assay of antioxidant enzymes, mitochondrial swelling, and histological analyses.

Determination of biochemical markers of hepatic injury {#S20007}
------------------------------------------------------

Blood was placed at room temperature for 1 h and then centrifuged at 1,000*g* for 10 min to obtain serum. The enzymatic activities of AST, ALT, and LDH were assayed spectrophotometrically according to Reitman and Frankel ([@CIT0025]), Bergmeyer ([@CIT0026]), and Allain et al. ([@CIT0027]), using a commercial kit (LABTEST, Diagnostica S.A., Minas Gerais, Brazil).

Oxidative damage biomarkers {#S20008}
---------------------------

Peroxidation of hepatic tissue lipids, *in vivo*, was measured by the method of Okawa et al. ([@CIT0028]). The amount of thiobarbituric acid-reactive substances (TBARS) was expressed as nmoles of TBARS formed per mg of protein and using a molar coefficient (ε) of 153 mmol/l per cm. Oxidative damage of proteins was quantified as carbonyl protein content according to the method of Levine et al. ([@CIT0029]). This method is based on spectrophotometric detection of the end product of the reaction of 2,4-dinitrophenylhydrazine with protein carbonyl to form protein hydrazones detected at 370 nm, and the results were expressed as nmoles of carbonyl group per mg of protein, using ε = 22 mmol/l per cm. Liver GSH levels were measured by a spectrophotometric method ([@CIT0030]) in acid hepatic homogenates combined with disodium hydrogen phosphate and DTNB solution, and the yellow chromophore formed was quantified at 412 nm using a molar coefficient (ε) of 14.1 mmol/l per cm. The results were expressed in µmol per mg of protein.

Detection of DNA damage {#S20009}
-----------------------

The extent of DNA fragmentation was assessed by the alkaline Comet assay proposed by Singh et al. ([@CIT0031]). Liver samples (100 mg) were homogenized in 1,000 µl phosphate-buffered saline (PBS) (1:9) and 10 µl of this solution was added to 70 µl of 0.75% low-melting point agarose. The cell/agarose mixture was added to a fully frosted microscope slide coated with a layer of 300 µl of normal-melting agarose (1%). The slides were immersed into a cold and freshly made lysis solution \[2.5 mM NaCl, 100 mM EDTA, 1% Triton X-100, 10% dimethyl sulfoxide (DMSO) and 10 mM Tris, pH 10\] for a minimum of 2 h. Subsequently, the slides were incubated in freshly prepared alkaline buffer (300 mM NaOH and 1.0 mM EDTA, pH 13) for 30 min. DNA was subjected to electrophoresis for 30 min at 280 mA and 25 V, and then neutralized with 0.4 M Tris, pH 7.5. Finally, DNA was stained with ethidium bromide (2.0 µg/ml). Images of 100 randomly selected cells (50 cells from each of two replicate slides) were analyzed from each animal and comet image lengths (nuclear region + tail) were measured in arbitrary units. A DNA damage index (DI) was compiled according to tail size, from undamaged (0) to maximally damaged (400), resulting in a single DNA damage score for each animal, and consequently, for each group studied. Thus, the DI of each group ranged from 0 (completely undamaged) to 400 (maximum damage).

Antioxidant enzymes {#S20010}
-------------------

Catalase (CAT) activity was determined by measuring at 240 nm the decrease of H~2~O~2~ in a freshly prepared 10 mM hydrogen peroxide solution; the results are expressed in mmol/min per mg protein and ε = 40 mmol/l per cm ([@CIT0032]). Superoxide dismutase (SOD) activity in homogenates was determined by measuring the inhibition of the rate of autocatalytic adrenochrome formation and expressed in U SOD/mg protein ([@CIT0033]). Glutathione peroxidase (GPx) activity was quantified by a coupled assay with glutathione reductase (GR) catalyzed oxidation of NADPH. Measurements were made at 340 nm and expressed in µmol/min per mg protein ([@CIT0034]). Protein was measured by the method of Lowry et al. ([@CIT0035]) using bovine serum albumin as standard.

Determination of mitochondrial swelling {#S20011}
---------------------------------------

Mitochondria were prepared from mouse liver according to the method of Aprille et al. ([@CIT0036]). In brief, livers of mice were excised and homogenized in an isolation buffer (225 mM d-mannitol, 75 mM sucrose, 0.05 mM EDTA, 10 mM Tris--HCl pH 7.4) at 4°C. The homogenates were centrifuged at 600*g* for 5 min and supernatants were centrifuged at 8,800*g* for 10 min. The pellet was washed twice with the same buffer. Protein concentration was determined by using Coomassie Brilliant Blue ([@CIT0037]).

Mitochondrial swelling was assessed by measuring the absorbance of their suspension at 540 nm ([@CIT0038]). Liver mitochondria isolated from each group of mice were dissolved at 0.5 mg protein per ml in 3 ml of the assay buffer (125 mM sucrose, 50 mM KCl, 2 mM KH~2~PO~4~, 10 mM HEPES, 5 mM succinate). To the assay buffer was added 50 mmol/l of Ca^2+^ to initiate mitochondrial swelling and the absorbance (A) at 0.5, 1, 2, 3, 4, 5, and 6 min was measured. The rate of mitochondrial swelling was calculated by using following formula:$$\left\lbrack \frac{\Delta\text{Abs}\text{.}_{\text{Test}} - \Delta\text{Abs}\text{.}_{\text{CC}\text{l}_{\text{4}}}}{\Delta\text{Abs}\text{.}_{\text{Control}} - \Delta\text{Abs}\text{.}_{\text{CC}\text{l}_{\text{4}}}} \right\rbrack \times 100\%\text{,}{\,\,\,}\,\text{where}{\,\,\,}\Delta = \text{Abs}\text{.}_{\text{0\ min}} - \text{Abs}\text{.}_{\text{6\ min}}$$

Histological analyses {#S20012}
---------------------

The hepatic duct was chosen (adjacent to liver) to standardize the histological analyses and to avoid misinterpretations. Samples of the same liver lobes (8--15 × 3--4 mm (for all treatments were fixed in 10% of formalin buffered with 0.1 M phosphate (pH 7.2). After fixation, samples were washed in tap water for 4 h and dehydrated through an increasing ethanol series, cleared, and embedded in 56--60% paraffin. Sections were cut at 5-µm thickness, stained with Cason\'s trichromic staining, and mounted in Eukit medium ([@CIT0039]). Histological sections were photographed under a light microscope with a digital image capture system (Olympus, model Dx 41).

Statistical analysis {#S20013}
--------------------

Data were expressed as means±SD. Statistical analysis was performed to compare treated groups with the respective control groups using one-sample Kolmogorov-Smirnov analysis of normality and two-way analysis of variance (ANOVA), followed by the Duncan\'s multiple range test where appropriate. Values of *p*\<0.01 were considered statistically significant.

Results {#S0014}
=======

In vitro antioxidant activity {#S20015}
-----------------------------

A marked difference in DPPH radical scavenging capacity was found: the isomeric mix of flavonolignans SIL showed a higher DPPH scavenging capacity than THA ([Table 1](#T0001){ref-type="table"}). Accordingly, SIL inhibited the generation of superoxide anion radicals to a greater extent than THA, but it is important to note that SIL concentration was about four-fold higher than that of THA. Curiously, no significant difference between SIL and THA was detected regarding both ^•^OH scavenging capacity and protection against membrane LPO ([Table 1](#T0001){ref-type="table"}).

###### 

*In vitro* antioxidant activity of THA and Silymarin measured by scavenging of DPPH, $O_{2}^{\bullet -}$and ^•^OH radicals, and protection against lipid peroxidation (LPO) (levels of thiobarbituric acid reactive substances) in hepatic homogenates

              IC~50~ (µg/ml)^[b](#TF0002){ref-type="table-fn"}^                                                           
  ----------- --------------------------------------------------- --------------------------------------------- --------- ----------
  THA         50.9±0.5^[a](#TF0001){ref-type="table-fn"}^         66.5±0.8^[a](#TF0001){ref-type="table-fn"}^   5.7±1.3   7.7±0.7
  Silymarin   13.9±0.7                                            45.4±1.5                                      7.6±0.8   10.1±0.5

Note: All values are expressed as means±SD (*n*=6).

Statistically significant compared to Silymarin (*p*\<0.01).

IC~50~: inhibitory concentration at 50% was obtained by linear regression.

Biochemical markers of hepatic injury {#S20016}
-------------------------------------

After 12 h since administration of CCl~4~ to mice, the levels of markers, such as ALT, AST, and LDH activities, were high in serum sample when compared with controls ([Table 2](#T0002){ref-type="table"}). Oral administration of THA or SIL significantly restored levels of these hepatic markers, except for LDH activity.

###### 

Effects of THA and Silymarin on CCl~4~-induced liver damage in mice

                       Serum Enzymes                                                                               
  -------------------- --------------------------------------------- --------------------------------------------- ---------------------------------------------------------------------------------
  Control group        29.2±3.5^[a](#TF0003){ref-type="table-fn"}^   9.1±1.1^[a](#TF0003){ref-type="table-fn"}^    237.2±38.3^[a](#TF0003){ref-type="table-fn"}^
  CCl~4~               91.0±1.5                                      38.4±1.6                                      541.4±41.2
  THA                  35.2±2.4^[a](#TF0003){ref-type="table-fn"}^   13.1±1.4^[a](#TF0003){ref-type="table-fn"}^   284.9±28.3^[a](#TF0003){ref-type="table-fn"},[b](#TF0004){ref-type="table-fn"}^
  THA + CCl~4~         30.9±2.3^[a](#TF0003){ref-type="table-fn"}^   10.5±1.0^[a](#TF0003){ref-type="table-fn"}^   272.4±33.7^[a](#TF0003){ref-type="table-fn"}^
  Silymarin            35.5±2.1^[a](#TF0003){ref-type="table-fn"}^   15.7±1.2^[a](#TF0003){ref-type="table-fn"}^   295.1±29.3^[a](#TF0003){ref-type="table-fn"}^
  Silymarin + CCl~4~   32.1±1.1^[a](#TF0003){ref-type="table-fn"}^   12.7±0.8^[a](#TF0003){ref-type="table-fn"}^   289.6±30.5^[a](#TF0003){ref-type="table-fn"},[b](#TF0004){ref-type="table-fn"}^

Note: ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase. Values are mean±SD (*n*=6).

*p*\<0.01 compared to CCl~4~-treated mice.

Compared to control group.

Oxidative damage biomarkers and DNA fragmentation {#S20017}
-------------------------------------------------

Pre-treatment of mice with THA or SIL had a remarkable antioxidant effect and prevented the LPO induced by CCl~4~ (82.7% and 83.3%, respectively) ([Fig. 2](#F0002){ref-type="fig"}A). In accordance with the results related to LPO, protein oxidation quantified as carbonyl protein content also showed a significant increase after CCl~4~ treatment (51.9%), which was significantly decreased by THA or SIL pre-treatment (35.8% and 31.2%, respectively) ([Fig. 2](#F0002){ref-type="fig"}B). In addition, fluorescence microscopy revealed that CCl~4~ caused remarkable DNA fragmentation (DI = 110.2±3.3) in hepatocyte homogenates when compared to the control group (DI = 49.0±1.0). On the other hand, DNA fragmentation in mice pre-treated with THA or SIL (DI = 51.0±2.0 and 45.0±4.0) was similar to that in control mice ([Fig. 2](#F0002){ref-type="fig"}C).

![Effect of THA (6 mg/kg body weight) or Silymarin (24 mg/kg body weight) on hepatic lipid peroxidation (A), protein carbonylation (B), and DNA damage Index (C) in CCl~4~-induced hepatotoxicity in mice. Bars represent means±SD, *n*=6. ^a^Significantly different from CCl~4~-treated mice (*p*\<0.01).](LJM-5-4891-g002){#F0002}

Glutathione (GSH) content and antioxidant enzymes {#S20018}
-------------------------------------------------

When administration of CCl~4~ to the mice resulted in approximately 60% depletion of hepatic GSH levels compared with controls ([Table 3](#T0003){ref-type="table"}). Pre-treatment with THA or SIL was effective in protecting hepatocytes against such depletion. On the other hand, CCl~4~ treatment resulted in a significant (*p*\<0.01) decrease of the hepatic enzymes CAT, SOD, and GPx when compared with the negative control group. THA or SIL pre-treatments prevented such decreases, which were within normal limits ([Table 3](#T0003){ref-type="table"}).

###### 

Effects of THA and Silymarin on GSH levels and antioxidant enzyme activities (CAT, SOD, and GPx) in livers of treated mice and of control mice

  Groups               GSH (µmol/mg protein)                           CAT (mmol/min/mg protein)                      SOD (U SOD/mg protein)                          GPx (µmol/min/mg protein)
  -------------------- ----------------------------------------------- ---------------------------------------------- ----------------------------------------------- -----------------------------------------------
  Control group        34.14±0.12^[a](#TF0005){ref-type="table-fn"}^   8.31±0.29^[a](#TF0005){ref-type="table-fn"}^   10.08±0.26^[a](#TF0005){ref-type="table-fn"}^   33.35±2.00^[a](#TF0005){ref-type="table-fn"}^
  CCl~4~               24.65±0.14                                      5.33±0.46                                      6.64±0.13                                       23.14±1.80
  THA                  30.72±0.18^[a](#TF0005){ref-type="table-fn"}^   7.87±0.31^[a](#TF0005){ref-type="table-fn"}^   8.45±0.45^[a](#TF0005){ref-type="table-fn"}^    34.68±1.10^[a](#TF0005){ref-type="table-fn"}^
  THA + CCl~4~         31.14±0.14^[a](#TF0005){ref-type="table-fn"}^   8.17±0.27^[a](#TF0005){ref-type="table-fn"}^   9.18±0.65^[a](#TF0005){ref-type="table-fn"}^    29.92±1.30^[a](#TF0005){ref-type="table-fn"}^
  Silymarin            32.06±0.22^[a](#TF0005){ref-type="table-fn"}^   7.70±0.33^[a](#TF0005){ref-type="table-fn"}^   10.27±0.39^[a](#TF0005){ref-type="table-fn"}^   32.79±1.42^[a](#TF0005){ref-type="table-fn"}^
  Silymarin + CCl~4~   29.82±0.15^[a](#TF0005){ref-type="table-fn"}^   7.43±0.15^[a](#TF0005){ref-type="table-fn"}^   14.01±0.73^[a](#TF0005){ref-type="table-fn"}^   31.97±1.50^[a](#TF0005){ref-type="table-fn"}^

Note: GSH, reduced glutathione; CAT, catalase; SOD, superoxide dismutase; GPx, glutathione peroxidase. Values are mean±SD (*n*=6).

*p*\<0.01 compared to the CCl~4~-treated mice.

Mitochondrial swelling {#S20019}
----------------------

Calcium-induced remarkable mitochondrial swelling in normal mice, which was greatly attenuated in mice pre-treated with CCl~4~ (46.9%) ([Fig. 3](#F0003){ref-type="fig"}), suggesting a decline in the sensitivity of mitochondria to swelling due to high calcium content. However, THA or SIL blocked such attenuation with inhibitory rates of 49.5% and 47.7%, respectively.

![Effect of THA (6 mg/kg body weight, by gavage) or Silymarin (24 mg/kg body weight, by gavage) on Ca^2+^-induced mitochondrial swelling. Bars represent means±SD for, *n*=6. ^a^Significantly different from CCl~4~-treated mice (*p*\<0.01).](LJM-5-4891-g003){#F0003}

Histological analyses {#S20020}
---------------------

Histological analyses revealed that in terms of morphology, livers subjected to all treatments generally showed normal structural integrity. The stromal and the parenchymal portions presented structural characteristics of healthy liver of mice. Intact hepatocytes plates were observed in fairly radial position in relation to the centrolobular vein with reticular fibers present on both sides. Plenty of capillary sinusoids of normal caliber and non-congestion were also observed. Hepatocytes were large and polyhedral, with round nuclei, abundant heterochromatin and nucleoli quite evident, all of which are characteristic of normal cells. However, when using Cason\'s staining, which can reveal distinct substrates with different colors, the CCl~4~ group ([Fig. 4](#F0004){ref-type="fig"}G) showed higher variation in color with two distinct populations of hepatocytes (separated by dashed lines). These cells exhibited a variety of substrates in the cytoplasm (as revealed by different staining), indicating that although initial morphological changes are not evident, there are indications of changes in hepatocyte metabolism. When the histological preparations are observed in a smaller magnification, the number of hepatocytes with different colors (and therefore with different metabolic activities) form groups quite limited under CCl~4~ treatment not clear ([Fig. 4](#F0004){ref-type="fig"}C, dashed lines). When comparing the other groups, the appearance in color (and thus in cell physiology) is very similar to each other ([Fig. 4](#F0004){ref-type="fig"}A--E, dotted lines), showing that the hepatoprotective treatments with THA ([Fig. 4](#F0004){ref-type="fig"}D) and SIL ([Fig. 4](#F0004){ref-type="fig"}E) were very effective against the hepatotoxic effects of CCl~4~.

![Histological analyses of liver in control mice (A), mice treated with THA (B), mice treated with CCl~4~ (C), mice pre-treated with THA followed by CCl~4~ (D), and mice pre-treated with Silymarin followed by CCl~4~ (E). Liver tissue was stained with trichromic Cason\'s staining (100×, bar = 100 µm). Photomicrographs F and G show histocytological details of normal and abnormal livers, respectively (Cason\'s staining 1000×, bar = 10 µm). Dashed lines separate the number of hepatocytes with different staining and arrows showed the nucleus and reticular fibers.](LJM-5-4891-g004){#F0004}

Discussion {#S0021}
==========

We demonstrate that THA has a concentration-dependent scavenging capacity for the DPPH radical higher than that of SIL, which is attributable to its hydrogen-donating ability. DPPH possesses a proton-free radical with the characteristics of absorption that decreases significantly on exposure of proton radical scavengers ([@CIT0040]).

In the present study, THA or SIL were able to scavenge $\text{O}_{2}^{\bullet -}$ in a concentration-dependent manner, measured by the xanthine/xanthine oxidase and NBT assays ([Table 1](#T0001){ref-type="table"}). Although the superoxide anion ($\text{O}_{2}^{\bullet -}$) is a relatively weak oxidant, it reacts to form more potent ROS, such as the hydroxyl radical (^•^OH), which initiate LPO processes ([@CIT0041]). Furthermore, superoxide anion ($\text{O}_{2}^{\bullet -}$) is also indirectly initiate the LPO as a result of H~2~O~2~ formation, creating precursors of ^•^OH ([@CIT0041]). Taking this into account, the results suggest that the antioxidant activity of THA is also related to its ability to scavenge the superoxide anion ($\text{O}_{2}^{\bullet -}$).

In the LPO assay, ^•^OH was scavenged by co-incubation of mouse liver homogenate with different concentrations of THA or SIL, and both phenolic compounds showed substantial and similar protection against membrane LPO ([Table 1](#T0001){ref-type="table"}). Furthermore, the evidence of ^•^OH scavenging activity of THA was obtained through the deoxyribose system, which displayed an IC~50~ close to that of SIL, thereby explaining such a strong protection against LPO. This property probably relies on the presence of phenolic hydroxyls at the *ortho* and *para* positions ([@CIT0011]). An early study that used this system to assess the biological activity of natural plant-derived biomolecules reported that molecules that can inhibit deoxyribose degradation are those that can chelate iron ions and render them inactive or poorly active for the Fenton reaction ([@CIT0042]). In summary, the *in vitro* results suggest that THA, which effectively scavenges several ROS, behaves in a way similar to SIL. The broad activity range related to THA suggests that multiple and synergistic mechanisms are probably responsible for the antioxidant activity of this acetophenone-derived substance.

CCl~4~ is known to cause hepatic damage manifested in marked elevation in serum levels of LDH and amino transferase enzymes (AST and ALT), especially ALT, which is considered the primary and specific marker of liver injury ([@CIT0043]). Accordingly, our results also showed a significant increase in the activities of AST, ALT, and LDH, thereby confirming the hepatocellular damage in CCl~4~-treated mice. A similar profile was observed by Hewawasam and collaborators ([@CIT0044]) in adult Swiss mice treated with CCl~4~ (0.5 ml/kg in olive oil). After pre-treatment with THA, the activities of these enzymes were decreased to values similar to those of controls ([Table 2](#T0002){ref-type="table"}). THA could also prevent the CCl~4~-induced increase in hepatic TBARS levels, suggesting that THA inhibits LPO and its propagation reactions ([Fig. 2](#F0002){ref-type="fig"}A). In addition, the histological analyses revealed typical toxicological effects on hepatocytes promoted by CCl~4~, as already described in the literature ([@CIT0045], [@CIT0046]). THA alone increased LDH levels in relation to controls but this enhancement was significantly lower than that observed in CCl~4~ treatment.

CCl~4~ causes marked toxicity by increasing the liver LPO, as detected by enhanced levels of hepatic TBARS ([@CIT0047], [@CIT0048]). As already mentioned, CCl~4~ hepatotoxicity depends on the reductive dehalogenation of CCl~4~ catalyzed by CYP450 in the hepatic endoplasmic reticulum, leading to the generation of an unstable complex of trichloromethyl peroxy radicals (CCl~3~ ^•^), which is reported to be a highly reactive species ([@CIT0005]). This free radical attacks membrane lipids, causing their peroxidation, and may also covalently bind to lipids and proteins, thereby initiating deleterious processes that ultimately leads to cell damage. THA may afford cell protection by impairing CCl~4~-mediated LPO, thus preventing the generation of free radical derivatives, if the ameliorated TBARS levels and mitochondrial sensitivity to calcium are taken into consideration ([Fig. 2](#F0002){ref-type="fig"}A).

Besides the finding that CCl~4~ increased LPO, it also depleted intracellular GSH levels, indicating that GSH loss might result from the detoxification of CCl~4~ by GSH conjugation. In addition, the previous enhancement of carbonyl protein contents was significantly prevented in mice treated with THA or SIL, suggesting a further antioxidant protection against protein oxidation. Therefore, these combined results strongly suggest that acetophenone acts as an antioxidant.

The histopathological analysis provided complementary evidence that pre-treatment with THA or SIL attenuated the cytoplasmatic changes in mouse liver induced by CCl~4~ administration. The hepatocyte plate of CCl~4~-treated mice resulted in cytophysiological changes shown by Cason\'s trichrome staining, revealing different colors in the cytoplasm ([Fig. 4](#F0004){ref-type="fig"}). This might have been due to the formation of highly reactive radicals associated with the oxidative threat induced by CCl~4~. Cellular accumulation of lipid hydroperoxides can cause cytotoxicity associated with peroxidation of membrane phospholipids by lipid hydroperoxides, the basis for a related cellular damage ([@CIT0041]). The cytophysiological changes coincided with increased levels of LPO ([Fig. 2](#F0002){ref-type="fig"}A), protein oxidation ([Fig. 2](#F0002){ref-type="fig"}B), and DNA fragmentation ([Fig. 2](#F0002){ref-type="fig"}C), while the administration of THA or SIL prevented such biochemical and histological alterations induced by CCl~4~. This effect could be attributable to the antioxidant activity of these two compounds, which significantly attenuated the oxidative threat and led to restoration of normal physiological functions.

In addition, the antioxidant enzymes CAT and GPx in mice pre-treated with THA or SIL and then treated with CCl~4~ had activities similar to those of controls ([Table 3](#T0003){ref-type="table"}). Treatment of mice with CCl~4~ concurrently induces processes in acute injury and also in regeneration, in which injury events are predominantly expressed at early stages, although this regeneration process is latent ([@CIT0049]). A possible reason why CAT and GPx activities were augmented after treatment with THA or SIL in the presence of CCl~4~ is the capacity of these compounds to counteract CCl~4~-induced massive ROS production ([@CIT0041]). Therefore, we speculate here that THA plays a role during the early stages in CCl~4~-induced liver injury, decreasing LPO and protein carbonylation and, consequently, improving cellular antioxidant status, thereby preventing ALT, AST, and LDH leakage from liver.

The activity of GPx, an important antioxidant enzyme that takes part in the enzymatic neutralization of free radicals, was significantly decreased by CCl~4~ treatment and normalized in mice pre-treated with THA or SIL. This result strongly suggests that CCl~4~, probably through its conversion to ${CC}\text{l}_{\text{3}}^{\bullet}$, the active metabolite produced in the liver after oral administration, inhibits the activity of GPx. In accordance with the response found in GPx, CAT activity also showed decreased values after CCl~4~ treatment, and again the pre-treatment with THA was able to normalize its activity. Taking into account the diminished GSH content together with the persistent enhancement of TBARS levels found in livers of mice treated with CCl~4~, these combined results suggest that this organ was facing a severe oxidative insult. It also strongly suggests that this process was reversed after THA treatment because THA possesses some antioxidant properties that can guarantee GSH maintenance probably through ROS neutralization.

In contrast to the toxic activation of CCl~4~ via P450 2E1 biotransformation process, the detoxification pathway also involves GSH conjugation of the ^•^CCl~3~, a P450 2E1-mediated CCl~4~ metabolite ([@CIT0050]). A previous study on the mechanism of CCl~4~-induced hepatotoxicity showed that GSH plays a key role in detoxifying the toxic metabolites of CCl~4~ and that liver necrosis begins when GSH stores are markedly depleted ([@CIT0004]). GSH levels are largely mediated by the activity of glutathione-S-transferase, generating adducts with the toxic metabolites of CCl~4~, and it has been suggested that one of the main causes of CCl~4~-induced liver injury is protein and LPO caused by its free radical derivatives ([@CIT0004]). As already mentioned, the present results showed that pre-treatment with THA or SIL significantly inhibited LPO, protein carbonylation, and DNA damage and that it also inhibited CCl~4~-induced hepatic GSH depletion.

ROS inflict damage on several cellular structures and functional components, including DNA, even under physiological conditions ([@CIT0041]). The present study showed a 52% enhancement of DNA fragmentation in mice exposed to CCl~4~ compared to the control group. However, DNA damage in liver was decreased in animals pre-treated with THA, suggesting that either the system of enzymatic repair was induced and/or an increase in antioxidant defenses in cell nuclei took place.

In conclusion, both the *in vitro* and the *in vivo* results indicate that THA can protect mouse liver from injury induced by CCl~4~ probably through its ROS scavenging ability. Nevertheless, further research must be carried out to verify the capacity of THA to block P450-mediated CCl~4~ bioactivation and also to elucidate the mechanisms regarding the hepatoprotective effect of THA at the molecular level.
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